330427006: Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\UK product\Virtual therapeutic moiety\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\UK product\Virtual therapeutic moiety\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H1 receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing ethylenediamine derivative and histamine receptor antagonist\Product containing antazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing imidazole\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Product manufactured as ocular dose form\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing xylometazoline in ocular dose form (medicinal product form)\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Antazoline + Xylometazoline\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops
\Medicinal product\Product containing autonomic agent\Product containing sympathomimetic\Product containing adrenergic receptor agonist\Product containing alpha adrenergic receptor agonist\Product containing xylometazoline\Product containing antazoline and xylometazoline\Product containing antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)\Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3692666015 Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3692667012 Antazoline sulfate 5 mg/mL and xylometazoline hydrochloride 500 microgram/mL eye drops en Synonym Active Only initial character case insensitive SNOMED CT core module

46752201000001115 Antazoline 0.5% / Xylometazoline 0.05% eye drops en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Product containing antazoline	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Miscellaneous eye preparations	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Antazoline	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Antazoline sulfate+xylometazoline hydrochloride	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Antazoline sulfate	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Xylometazoline hydrochloride	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Bronchodilator	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Product containing antazoline and xylometazoline	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Ocular dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Conventional release eye drops	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Product containing xylometazoline in ophthalmic dosage form	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength denominator unit	Milliliter	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength denominator unit	Milliliter	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength numerator value	5	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength numerator value	500	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has concentration strength numerator unit	microgram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has basis of strength substance	Antazoline sulfate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has precise active ingredient	Xylometazoline hydrochloride	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has precise active ingredient	Antazoline sulfate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has basis of strength substance	Xylometazoline hydrochloride	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has unit of administration	drop	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Xylometazoline	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Ocular	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has unit of administration	drop	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Conventional release eye drops	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	solutiondrops.ophthalmic ontology form and route	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Ophthalmic route	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Continuous dose form indicator	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Ocular dose form	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has active ingredient	Antazoline	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Drops	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Conventional release eye drops	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Conventional release eye drops	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Antazoline + Xylometazoline	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has manufactured dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has specific active ingredient	Xylometazoline hydrochloride	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has specific active ingredient	Antazoline sulfate	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has dispensed dose form	Drops dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has dispensed dose form	Conventional release eye drops	true	Inferred relationship	Existential restriction modifier
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Has unit of administration	drop	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Antazoline sulphate+xylometazoline hydrochloride 0.5/0.05% eye drops - product	Is a	False	Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Inferred relationship	Existential restriction modifier
Otrivine Antistin 0.5%/0.05% eye drops (Novartis Consumer Health UK Ltd)	Is a	True	Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Inferred relationship	Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml	Is pack of	False	Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Inferred relationship	Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml	Has VMP	True	Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692666015	Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3692667012	Antazoline sulfate 5 mg/mL and xylometazoline hydrochloride 500 microgram/mL eye drops	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
46752201000001115	Antazoline 0.5% / Xylometazoline 0.05% eye drops	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module